The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Linda Yaccarino became CEO of eMed Population Health on August 5, 2025, about a month after announcing her departure from X. The move takes the former advertising and media executive into digital health, where eMed focuses on GLP-1 and GIP medication management for obesity and type 2 diabetes.
For patients, employers and benefits managers, the important distinction is that eMed is not a drugmaker. It presents itself as a telehealth and population-health platform that combines screening, clinician review, prescription coordination, medication access and ongoing monitoring.
As an Amazon Associate I earn from qualifying purchases.
What happened to Linda Yaccarino?
eMed announced on August 5, 2025 that Yaccarino had joined the company as its chief executive officer. This was an operating CEO appointment—not a board, advisory or investment role, according to the appointment announcement.
Yaccarino had announced in July 2025 that she was stepping down as CEO of X after roughly two years in the role. Reuters reported on her departure, while another Reuters account described the move to eMed as occurring approximately one month later.
#1 Best Overall
- Health Monitoring Features: Track your heart rate and blood pressure 24/7, empowering you to stay proactive about your well-being. Dive into insightful sleep monitoring to optimize your rest for peak performance. Stay informed about your 02 levels for enhanced vitality. Plus, find moments of tranquility with guided breathing exercises, all from your wrist. Discover a smarter approach to a healthier lifestyle with FITVII fitness tracker.(Only for encouraging a healthy lifestyle, not for medical use)
- Fitness Tracking Capabilities: Elevate your fitness journey with FITVII fitness tracker's extensive tracking capabilities. Monitor your daily activities effortlessly, from steps taken to calories burned and distance traveled. With over 120+ sports modes, you'll find the perfect fit for your workout routine, whether you're hitting the gym or exploring the great outdoors
- Convenient Reminders: Stay on track throughout your day with FITVII smart watch reminders. Avoid prolonged periods of inactivity with sedentary reminders and stay hydrated with drinking water reminders. Women's health feature tracks your menstrual time and record menstrual changes to learn more about your body. Never miss an appointment with our alarm clock feature, keeping you punctual and organized
- Handy Bluetooth Features: FITVII fitness watch goes beyond health and fitness, offering a range of convenient features. Built-in AAC Audio Technology, enjoy crystal-clear Bluetooth calls directly from your wrist. Receive texts and app notifications, locating your misplaced phone has never been easier. Enjoy your favorite tunes on the go with Bluetooth music playback control, and capture memories effortlessly with remote camera control, all from the convenience of your wrist
- Practical Utility Features: Experience convenience at your fingertips with FITVII smartwatch's array of practical functions. Stay ahead of the weather with real-time forecasts delivered directly to your wrist. Whether you're timing laps at the track or tracking your workout, our stopwatch and countdown timer ensure precision. Keep your schedule organized with easy access to your calendar. Stay connected with quick access to your contacts. Need to crunch some numbers? Our built-in calculator has you covered
The available reporting does not establish that she left X because of a particular dispute. The documented fact is the timing: a rapid move from a social-media company into a healthcare business.
What is eMed?
eMed is a Miami-based digital-health and telehealth company. Its business is centered on what it calls GLP-1/GIP population-health management, particularly for obesity and type 2 diabetes care.
GLP-1 and GIP medicines are prescription treatments used in diabetes and, for eligible patients, weight-management care. eMed does not manufacture those medicines. Instead, the company says its platform can coordinate:
- At-home screening and biomarker collection
- Medical-history questionnaires
- Review by licensed clinicians
- Prescription decisions when clinically appropriate
- Medication sourcing and delivery
- Weekly check-ins and side-effect support
- Weight, dose, adherence and biomarker monitoring
- Lifestyle and digital support
That makes eMed different from a simple prescription marketplace. It positions itself as a combination of a clinical service, medication-management program, diagnostics platform and employer-benefits offering. Its company overview and employer materials describe both individual and employer-facing programs.
Why would eMed hire an advertising executive?
The strongest documented rationale is commercial rather than clinical. The appointment announcement emphasized Yaccarino’s experience with partnerships, digital platforms, brand building and growth. Reuters also reported that eMed works with employers and government payers to manage GLP-1 use.
That background may be useful because the next phase of GLP-1 care is not only about writing prescriptions. Companies also compete on patient acquisition, affordability, adherence, employer distribution, engagement and the ability to operate at scale.
In that sense, Yaccarino appears to have been hired for commercial execution and distribution, not medical authority. She is not presented in the available sources as a physician or clinical specialist. Her business experience also does not automatically transfer to the regulatory, privacy, safety and clinical-governance requirements of telehealth.
Yaccarino’s career before eMed
Yaccarino spent much of her career in advertising and media. She worked for more than a decade at NBCUniversal, where she led advertising operations and related commercial initiatives. In 2023, she became CEO of X under Elon Musk’s ownership.
Rank #2
- 【Advanced Health Fitness Tracker】-This fitness tracker offers 24/7 heart rate and blood pressure monitoring to help you stay proactive about your health goals. It also supports on-demand blood oxygen checks, so you can quickly see your O₂ level whenever you need it. Detailed sleep tracking (deep sleep, light sleep and wake-ups) and all-day activity tracking give you a clearer picture of your overall health trends. (Inspire a healthy life, not for medical use
- 【All-Day Activity & Fitness Tracking】-The MorePro fitness tracker for women and men offers 120+ sport modes including running, walking and more, so you can track the workouts you actually do. With a built-in pedometer step counter, this smart watch records steps, distance, calories burned, heart rate and training time in real time, giving you clear references for exercise intensity. Whether you’re at the gym, on a run or playing ball with friends, every workout becomes safer, more efficient and easier to enjoy
- 【Women’s Health & Cycle Tracking】-Designed as a women’s health tracker, the smart watches for women offers intuitive menstrual cycle tracking right on your wrist. Use the built-in period tracker to log your menstrual period, safe days, ovulation window and ovulation day, while the app supports period mode, trying-to-conceive mode and pregnancy mode to match different life stages. Whether you’re at work, in class or relaxing at home, gentle women’s health reminders help you prepare in advance with the right clothes and pads, so every month feels more predictable and in control
- 【Everyday Smart Lifestyle Companion】-Stay connected without constantly checking your phone. This smart watch fitness tracker delivers real-time call, SMS and app message notifications on your wrist, so you can see who’s contacting you while you’re in a meeting, commuting or working out. The IP68 waterproof design easily handles sweat, rain and hand-washing. With over 200 watch faces and simple DIY custom faces using your own photos, you can quickly match your watch to business, workout or casual looks
- 【Practical Daily Smart Tools】-From sedentary reminders and drink water reminders to on-wrist weather forecasts, this smart watch helps you build healthier routines at work or while studying. Use music control and camera control while your phone stays in your bag, and rely on the stopwatch, timer, alarm clock and find my phone features to keep workouts, cooking and busy mornings on track
At X, her work included efforts to rebuild advertiser confidence and restore advertising revenue during a period marked by controversy over content moderation, brand safety and Musk’s public conduct. Those efforts made partnerships and advertiser relationships central to her role, but the available coverage does not support presenting her tenure as an unqualified turnaround.
Her eMed appointment therefore represents a significant sector change:
| At X | At eMed |
|---|---|
| Social platform and advertising business | Digital-health and telehealth platform |
| Advertiser relationships and brand safety | Clinical delivery and medication management |
| Consumer technology scale | Employer, payer and patient health programs |
| Revenue recovery and partnerships | Access, adherence, monitoring and health outcomes |
How eMed’s programs work
For an employer-sponsored program, eMed describes a workflow that generally begins with enrollment through its app. The user completes an at-home screening process, provides health and biomarker information, and fills out a medical-history questionnaire. Licensed clinicians then review the information and decide whether treatment is appropriate.
If approved, medication may be delivered to the patient. The company describes continuing check-ins, side-effect support and monitoring of weight, dosage, adherence and biomarkers. Employers receive aggregated reporting, according to eMed, rather than individual health information or participation data.
That privacy distinction matters to employees considering an employer program. However, the exact data practices depend on the applicable privacy notice, benefit arrangement and employer contract. Employees should review those terms rather than assume that every form of participation data is handled identically.
Pricing and eligibility
Prices are volatile and differ between individual enrollment and employer arrangements. On eMed’s individual program page, prices displayed on August 16, 2026 included:
- $49: one-time application and screening fee
- From $149.99 per month: prescription medication, paid only if approved
- $149.99 per month: eMed membership fee
These figures are shown on eMed’s individual signup page and should not be treated as permanent pricing. Eligibility, medication availability, insurance treatment and fees can change.
Recommended Free Tools
A separate healthcare-system offer lists starting prices of $25 per employee per month for employers and $99 per month for employees for clinical care and FDA-approved GLP-1 medications across doses. That appears to be a segment-specific offer, not a universal employer price; the details are listed at eMed’s healthcare-system page.
Paying a program or membership fee does not guarantee approval or medication access. A licensed clinician must review the patient, and treatment remains subject to clinical eligibility, prescription requirements, availability and applicable safety information.
Rank #3
- Designed with a bright, colorful AMOLED display, get a more complete picture of your health, thanks to battery life of up to 11 days in smartwatch mode
- Body Battery energy monitoring helps you understand when you’re charged up or need to rest, with even more personalized insights based on sleep, naps, stress levels, workouts and more (data presented is intended to be a close estimation of metrics tracked)
- Get a sleep score and personalized sleep coaching for how much sleep you need — and get tips on how to improve plus key metrics such as HRV status to better understand your health (data presented is intended to be a close estimation of metrics tracked)
- Find new ways to keep your body moving with more than 30 built-in indoor and GPS sports apps, including walking, running, cycling, HIIT, swimming, golf and more
- Wheelchair mode tracks pushes — rather than steps — and includes push and handcycle activities with preloaded workouts for strength, cardio, HIIT, Pilates and yoga, challenges specific to wheelchair users and more (data presented is intended to be a close estimation of metrics tracked)
What eMed says about its scale
According to eMed’s latest official “About” page, the company reports more than 1,200 clients, more than 6 million users and more than 25 million tests. It also describes a relationship with Aon, including a strategic investment, and relationships involving Thrive Global and CVS Health.
The same page reports that eMed raised $200 million at a valuation above $2 billion. These are company-reported figures; the available material does not independently audit or verify each number.
There is also an apparent inconsistency across eMed’s website: an older page lists Wendi Mader as CEO, while newer official pages identify Yaccarino. The latest “About” page and homepage support describing Yaccarino as the current CEO, but the company’s pages are not perfectly synchronized.
What remains unproven
eMed’s website makes claims about adherence, weight loss, biomarker changes and potential cost savings. Some results are identified as internal or corporate-partner data. That does not necessarily make them unreliable, but it means readers should not treat them as independently proven clinical outcomes without more information.
Important questions include:
- How many people were included?
- How were participants selected?
- How long were they followed?
- Was there a control group?
- Were outcomes measured across all users or only selected cohorts?
- Were medication costs included in savings calculations?
- Have the findings been independently validated or peer-reviewed?
Individual results vary, and a digital program cannot guarantee weight loss, clinical improvement or medication access. Employers evaluating eMed should separately examine clinical governance, prescribing oversight, data protection, total costs, outcome methodology and what reporting they will receive.
What the appointment signals
Yaccarino’s move suggests that GLP-1 companies increasingly need more than a prescribing pathway. The competitive questions now include how to reach patients, retain them, support adherence, work with employers and payers, control costs and build trust around sensitive health data.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Her experience may help eMed with those commercial and distribution challenges. The central test will be whether the company can pair that growth expertise with strong medical leadership, compliance systems and transparent evidence. Experience scaling a media platform can support a health-tech business, but it cannot replace clinical credentials or independent validation of health outcomes.
What patients and employers should check
- Whether the quoted price includes medication, membership, consultations, laboratory work and delivery
- What happens if a clinician does not approve treatment
- Whether the desired medication is actually available
- How compounded or branded medicines, if offered, are described and regulated
- What health information is collected and who can access it
- Whether employer reports are aggregated and how small groups are handled
- What evidence supports claimed weight, adherence or cost outcomes
- Which clinician or care team handles side effects and follow-up
For patients, eMed should be compared with primary-care physicians, endocrinologists, obesity-medicine clinics and other digital-care providers based on clinical fit, total cost, continuity of care and privacy—not simply celebrity leadership or headline pricing.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
